Central nervous system and body weight regulation

Area of Science:

• Neuroendocrinology
• Obesity Pathophysiology
• Metabolic Syndrome

Background:

• The hypothalamus is central to obesity etiology, with neuropeptide Y (NPY) and leptin being critical regulators.
• Obesity is often characterized by elevated hypothalamic NPY levels, leading to hyperphagia and associated metabolic disturbances.
• Leptin, secreted by adipose tissue, normally reduces NPY and food intake, but its effectiveness is compromised in many obese individuals.

Purpose of the Study:

• To elucidate the roles of neuropeptide Y and leptin in the pathophysiology of obesity syndromes.
• To explain how hypothalamic dysregulation by factors like insulin, leptin, and glucose availability contributes to obesity.
• To understand the interplay between NPY, leptin, hyperinsulinemia, and hypercorticism in maintaining obesity.

Main Methods:

• Analysis of animal models of obesity to understand hypothalamic regulation.
• Investigation of the effects of neuropeptide Y as an orexigenic agent.
• Examination of leptin's anorectic actions and its secretion influenced by insulin and glucocorticoids.

Main Results:

• Elevated hypothalamic NPY levels in obese models cause hyperphagia, hyperinsulinemia, and hypercorticism, explaining many obesity-related disorders.
• Leptin administration normalizes metabolic abnormalities in leptin-deficient mice (ob/ob strain).
• In most obese rodents and humans, high leptin levels coexist with central leptin resistance, creating a vicious cycle with NPY.

Conclusions:

• Neuropeptide Y and leptin highlight the brain-periphery connection in obesity, particularly between the hypothalamus and adipose tissue.
• Dysfunctional leptin signaling or NPY excess perpetuates obesity through a cycle of hyperphagia, insulin resistance, and fat accretion.
• Development of NPY antagonists or leptin agonists is crucial for managing obesity resulting from these dysregulations.